.

Deeper Knowledge, Faster

  • Analyze global market entry opportunities
  • Drug patents in 130+ countries
  • Set up watchlists for daily email updates

► See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Colorcon
Deloitte
Julphar
Accenture
Farmers Insurance
Fuji
UBS
Novartis
Johnson and Johnson
AstraZeneca

Generated: June 27, 2017

DrugPatentWatch Database Preview

Details for Patent: 4,335,125

« Back to Dashboard

Summary for Patent: 4,335,125

Title: 1-(1,3-Dioxolan-2-ylmethyl)-1H-imidazoles
Abstract:Novel 1-(1,3-dioxolan-2-ylmethyl)-1H-imidazoles and 1H-1,2,4-triazoles useful as antifungal and antibacterial agents.
Inventor(s): Heeres; Jan (Vosselaar, BE), Backx; Leo J. J. (Arendonk, BE), Mostmans; Joseph H. (Antwerp, BE)
Assignee: Janssen Pharmaceutica, N.V. (Beerse, BE)
Application Number:06/001,613
Patent Claim Types:
see list of patent claims
Compound; Composition;

No matches for this query

International Patent Family for Patent: 4,335,125

Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
AustriaA63678► Subscribe
Austria366683► Subscribe
Australia521329► Subscribe
Australia3285078► Subscribe
Belgium863382► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

The estimated expiration dates shown above are derived by simply adding 20 years to the priority date.
Due to the complexity of determining patent expirations even in a single country, compounded by the diversity of global patent laws, it is advisable to have patent counsel verify freedom to operate.

Export unavailable in trial.
Subscribe for complete access.

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Harvard Business School
Federal Trade Commission
Citi
US Army
Cantor Fitzgerald
Deloitte
Fish and Richardson
Express Scripts
Medtronic
Dow

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot